Skip to content Synspira
Synspira Mobile Menu Toggle navigation
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Progressive
      Pulmonary Disease
    • Malabsorption
      Syndromes
  • Patient Focus
    • Cystic Fibrosis
    • Other Rare
      Disease Areas
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Progressive
      Pulmonary Disease
    • Malabsorption
      Syndromes
  • Patient Focus
    • Cystic Fibrosis
    • Other Rare
      Disease Areas
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact

Category: Presentations

In vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus

Posted on August 3, 2018March 20, 2019 by Kathryn Kilroy
Posted in Presentations

Novel glycopolymer eradicates antibiotic- and CCCP- induced persister cells in Pseudomonas aeruginosa

Posted on January 17, 2018March 20, 2019 by Kathryn Kilroy
Posted in Presentations

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem

Posted on June 29, 2017March 20, 2019 by Kathryn Kilroy
Posted in Presentations
  • Privacy Policy
  • Terms & Conditions
  • FCOI Policy
  • LinkedIn
  • Twitter

©2023 Synspira Therapeutics Inc.

All Rights Reserved.